Literature DB >> 31955506

An overview of hypertension and cardiac involvement in Asia: Focus on heart failure.

Arieska Ann Soenarta1, Peera Buranakitjaroen2, Yook-Chin Chia3,4, Chen-Huan Chen5, Jennifer Nailes6, Satoshi Hoshide7, Huynh Van Minh8, Sungha Park9, Jinho Shin10, Saulat Siddique11, Jorge Sison12, Guru Prasad Sogunuru13,14, Apichard Sukonthasarn15, Jam Chin Tay16, Boon Wee Teo17, Yuda Turana18, Narsingh Verma19, Tzung-Dau Wang20, Yu-Qing Zhang21, Ji-Guang Wang22, Kazuomi Kario7.   

Abstract

Cardiovascular Disease (CVD) is the leading cause of deaths worldwide, contributing to about 30% of all deaths. Half of the cases of CVD are estimated in Asia, the world's most populous continent. Hypertension, a major modifiable risk factor for CVD, results in more deaths than any other CV risk factors in the Asian regions. The total number of patients with hypertension is likely to grow as the population ages. The proportion of the elderly population aged 65 years or more in Asia is expected to increase from 7.4% in 2015 to 10.9% in 2030. It is important to note that more than half (54%) of the world's population live in Asia. Aside of being the biggest single risk factor for global deaths, hypertension is also an important precursor and most common risk factor of heart failure (HF). An increase in HF prevalence is clearly related to the rapid epidemiological transition caused by changes in lifestyle in Asian countries. However, the availability of data on HF burden and health care delivery is limited in Asia compared with Europe and North America. This reality has driven the working group of Asian experts for example the HOPE Asia Network to concentrate on hypertension as risk factors for CVD, with the mission to improve the management of hypertension resulting in organ protection toward a goal of achieving "ZERO" CV event in Asia. This paper aims to give an overview regarding the heart problems caused by hypertension in Asia, focus on HF.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Asia; heart failure with preserved/reduced ejection fraction; hypertension

Mesh:

Year:  2020        PMID: 31955506      PMCID: PMC8029815          DOI: 10.1111/jch.13753

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  53 in total

Review 1.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

2.  Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.

Authors:  Vincent M van Deursen; Renato Urso; Cecile Laroche; Kevin Damman; Ulf Dahlström; Luigi Tavazzi; Aldo P Maggioni; Adriaan A Voors
Journal:  Eur J Heart Fail       Date:  2013-12-19       Impact factor: 15.534

Review 3.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

Review 4.  Consensus Document on Improving Hypertension Management in Asian Patients, Taking Into Account Asian Characteristics.

Authors:  Kazuomi Kario; Chen-Huan Chen; Sungha Park; Chang-Gyu Park; Satoshi Hoshide; Hao-Min Cheng; Qi-Fang Huang; Ji-Guang Wang
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

Review 5.  From hypertension to heart failure -- are there better primary prevention strategies?

Authors:  Peter A Meredith; Jan Ostergren
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2006-06       Impact factor: 1.636

6.  Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Authors:  Dalane W Kitzman; Peter Brubaker; Timothy Morgan; Mark Haykowsky; Gregory Hundley; William E Kraus; Joel Eggebeen; Barbara J Nicklas
Journal:  JAMA       Date:  2016-01-05       Impact factor: 56.272

7.  Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry.

Authors:  Carolyn S P Lam; Tiew-Hwa Katherine Teng; Wan Ting Tay; Inder Anand; Shu Zhang; Wataru Shimizu; Calambur Narasimhan; Sang Weon Park; Cheuk-Man Yu; Tachapong Ngarmukos; Razali Omar; Eugene B Reyes; Bambang B Siswanto; Chung-Lieh Hung; Lieng H Ling; Jonathan Yap; Michael MacDonald; A Mark Richards
Journal:  Eur Heart J       Date:  2016-08-07       Impact factor: 29.983

8.  Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis.

Authors:  Carlene M M Lawes; Derrick A Bennett; Varsha Parag; Mark Woodward; Gary Whitlock; Tai Hing Lam; Il Suh; Anthony Rodgers
Journal:  Hypertension       Date:  2003-05-19       Impact factor: 10.190

9.  The Prevalence and Social Determinants of Hypertension among Adults in Indonesia: A Cross-Sectional Population-Based National Survey.

Authors:  Karl Peltzer; Supa Pengpid
Journal:  Int J Hypertens       Date:  2018-08-09       Impact factor: 2.420

10.  May Measurement Month 2017: Results of 39 national blood pressure screening programmes.

Authors:  Neil R Poulter; Claudio Borghi; Rafael R Castillo; Fadi J Charchar; Agustin J Ramirez; Markus P Schlaich; Aletta E Schutte; George Stergiou; Thomas Unger; Richard D Wainford; Thomas Beaney
Journal:  Eur Heart J Suppl       Date:  2019-04-24       Impact factor: 1.803

View more
  8 in total

Review 1.  Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis.

Authors:  Morgan Connaughton; Mahsa Dabagh
Journal:  Healthcare (Basel)       Date:  2022-06-09

2.  The possibility that long-term isometric handgrip exercise contributes to left atrial enlargement in patients with hypertension.

Authors:  Yuta Kemi; Satoshi Hoshide; Eiji Yamashita; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-08       Impact factor: 3.738

3.  Prediction of single-cell mechanisms for disease progression in hypertrophic remodelling by a trans-omics approach.

Authors:  Momoko Hamano; Seitaro Nomura; Midori Iida; Issei Komuro; Yoshihiro Yamanishi
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

4.  Changes in prevalence and risk factors of hypertension among adults in Bangladesh: An analysis of two waves of nationally representative surveys.

Authors:  Muhammad Abdul Baker Chowdhury; Mirajul Islam; Jakia Rahman; Mohammed Taj Uddin; Md Rabiul Haque; Md Jamal Uddin
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 5.  Targets and management of hypertension in heart failure: focusing on the stages of heart failure.

Authors:  Huanhuan Miao; Changhong Zou; Shijie Yang; Yook-Chin Chia; Minh Van Huynh; Guru Prasad Sogunuru; Jam Chin Tay; Tzung-Dau Wang; Kazuomi Kario; Yuqing Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

Review 6.  An overview of hypertension and cardiac involvement in Asia: Focus on heart failure.

Authors:  Arieska Ann Soenarta; Peera Buranakitjaroen; Yook-Chin Chia; Chen-Huan Chen; Jennifer Nailes; Satoshi Hoshide; Huynh Van Minh; Sungha Park; Jinho Shin; Saulat Siddique; Jorge Sison; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Narsingh Verma; Tzung-Dau Wang; Yu-Qing Zhang; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

7.  Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.

Authors:  Hiromi Rakugi; Kazuomi Kario; Masako Yamaguchi; Takayoshi Sasajima; Hiromi Gotou; Jack Zhang
Journal:  Hypertens Res       Date:  2022-01-21       Impact factor: 5.528

Review 8.  The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.